Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Israel

Israel: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.1% in 2024. ◆ Volatile

Latest (2024)
0.1%
Change on year
unchanged
World rank
112th
of 215 countries
All-time high
0.4%
in 2015
All-time low
0.1%
in 2020
Years of data
10
2015–2024

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Israel, 2015–2024

0.10.20.30.42015201920242015: 0.42016: 0.32017: 0.32018: 0.22019: 0.22020: 0.12021: 0.12022: 0.12023: 0.12024: 0.1

Source: United Nations Statistics Division, SDG Global Database.

Analysis

Israel recorded 0.1% for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in 2024. That is the lowest value across all 10 years on record.

The figure is down 75.0% over ten years.

Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Israel peaked at 0.4% in 2015 and was at its lowest, 0.1%, in 2020.

That places Israel 112th out of 215 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Israel, year by year

Annual values for Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%) in Israel, 2015 to 2024.
Year Value Change
2015 0.4%
2016 0.3% -25.0%
2017 0.3% +0.0%
2018 0.2% -33.3%
2019 0.2% +0.0%
2020 0.1% -50.0%
2021 0.1% +0.0%
2022 0.1% +0.0%
2023 0.1% +0.0%
2024 0.1% +0.0%

Averages by decade

DecadeAverage LowestHighest Years
2010s 0.3% 0.2% 0.4% 5
2020s 0.1% 0.1% 0.1% 5

Countries ranked near Israel

  1. 112 Albania 0.1% compare
  2. 112 Algeria 0.1% compare
  3. 112 Armenia 0.1% compare
  4. 112 Australia 0.1% compare
  5. 112 Belize 0.1% compare
  6. 112 Bhutan 0.1% compare
  7. 112 China 0.1% compare
  8. 112 Denmark 0.1% compare
  9. 112 Dominican Republic 0.1% compare
  10. 112 Gambia 0.1% compare
  11. 112 Guam 0.1% compare
  12. 112 Guyana 0.1% compare
  13. 112 Hungary 0.1% compare
  14. 112 Jordan 0.1% compare
  15. 112 Kyrgyzstan 0.1% compare
  16. 112 Lebanon 0.1% compare
  17. 112 Lithuania 0.1% compare
  18. 112 Malaysia 0.1% compare
  19. 112 Oman 0.1% compare
  20. 112 Paraguay 0.1% compare
  21. 112 Peru 0.1% compare
  22. 112 Romania 0.1% compare
  23. 112 Russian Federation 0.1% compare
  24. 112 Serbia 0.1% compare
  25. 112 Singapore 0.1% compare
  26. 112 Thailand 0.1% compare
  27. 112 Trinidad and Tobago 0.1% compare
  28. 112 Tunisia 0.1% compare
  29. 112 Ukraine 0.1% compare
  30. 112 Uzbekistan 0.1% compare

See the full ranking of 236 places →

More development goals data for Israel

All data for Israel →

Frequently asked questions

What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Israel?
Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Israel was 0.1% in 2024, according to United Nations Statistics Division, SDG Global Database.
What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Israel?
The highest recorded value was 0.4% in 2015.
What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Israel?
The lowest recorded value was 0.1% in 2020.
How does Israel rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
Israel ranks 112th out of 215 countries with data for 2024.
Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Israel?
Over the last ten years it is down 75.0%. The long-run trend across the full record is volatile.
Where does this Israel data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Israel. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 29 August 2026, from https://development-goals.statizoid.com/stat/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/israel/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/stat/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/israel/">Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Israel</a> — Statizoid

About this data

Indicator
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
236 places, 2,360 data points, 2015–2024
Last refreshed